In our study, the loss of the ability of the gut microbiota of HF patients to induce an inflammatory response was confirmed by in vitro studies, since NF-κB activation was higher in colonic HT29 cells exposed to fecal samples collected at admission than in those collected after 12 months of follow-up. This evidence concerns the gene NFKB1 and hydrops fetalis.